---
title: ""Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised"
date: The Lancet Neurology
enddate:
---

Published in: * controlled*

DOI: [ open-label](https://doi.org/ open-label)

The publication DOI could not be resolved by Unpaywall. It may or may not be available in Open Access.


